BIM and SHP2 expression levels to predict clinical outcome to EGFR tyrosine kinase inhibitors (TKI) in EGFR-mutant non-small-cell lung cancer (NSCLC) patients (p)

García Campelo, María del Rosario; Alonso-Jaudenes Curbera, Guillermo

Statistics

Statistics

View Usage Statistics

Identifiers

Identifiers

URI: http://hdl.handle.net/20.500.11940/1489

ISSN: 0732-183X

Full record

Services

Services

RIS

Mendeley

Linksolver

Date issued

2015

Journal title

Journal Of Clinical Oncology

Type of content

Publicación de congreso